Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127161161 | 12716116 | 1 | I | 20160825 | 20160826 | 20160906 | 20160906 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-55968BP | BOEHRINGER INGELHEIM | 19.59 | YR | M | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127161161 | 12716116 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG | 655401 | 20520 | 75 | MG | TABLET | ||||||
| 127161161 | 12716116 | 2 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 655401 | 20520 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127161161 | 12716116 | 1 | Dyspepsia |
| 127161161 | 12716116 | 2 | Dyspepsia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127161161 | 12716116 | Drug screen positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127161161 | 12716116 | 1 | 20160815 | 20160825 | 0 |